Drug intelligence / Profile preview

flunitrazepam

Development stage
Unknown
Lead developer
Roche
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Flunitrazepam is a potent benzodiazepine derivative with strong hypnotic and sedative effects. It acts as a central nervous system (CNS) depressant and is used for the short-term treatment of severe insomnia and as a premedication for anesthesia in countries where it is approved. Its mechanism of action involves enhancing the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter at GABA-A receptors in the brain. This results in sedation (drowsiness), muscle relaxation (skeletal muscle relaxant properties), anxiolysis (reduction of anxiety), and amnesia (memory loss). The drug has a long half-life due to active metabolites. It was patented in 1962 and came into medical use in 1974.[4][6] Flunitrazepam is not approved for medical use in the United States but is available elsewhere under various brand names such as Rohypnol. It has gained notoriety as a "date rape" drug due to its ability to cause anterograde amnesia when administered surreptitiously.[1][3]

Brand names
RohypnolNarcozepFluninocFluni 1A PharmaFluni1A PharmaFluni-1A PharmaFlunibetaFlunimerck
Other names
CirclesForget Me PillLa RochaLunch Money DrugMexican ValiumPingusR2R-2R 2Roach 2Roach2Roach-2RuffiesRophiesWolfiesForget PillForget-Me-PillReynoldsRoachRoachesRoachiesRoapiesRobutalRochas DosRopeRow-ShayMind EraserRibRoofieFoonie
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on flunitrazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flunitrazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call